By analyzing survival data of HB patients, we could demonstrate that high NPM1 expression was associated with poor event-free survival, and showed a trend towards poor overall survival (Fig. 3 m).
← all excerpts
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.
1
—
—